Eli Lilly Q1 2020 earnings in graphical representation

[anonymous]

Pharmaceutical company Eli Lilly (LLY) reported first-quarter 2020 revenue of $5.86 billion, up 15% year-over-year.

Amid COVID-19 pandemic, the company saw increased customer buying patterns and prescription trends which resulted in a revenue increase of approx. $250 million for the quarter.

The company has adjusted its earnings guidance for the full year 2020.

The graphical representation of the earnings results can be found here.

 

[anonymous]

Taltz is really starting to gain steam. Great leadership, even better people and a great product= strong sales! So happy to be part of this organization!

 

[anonymous]

Pharmaceutical company Eli Lilly (LLY) reported first-quarter 2020 revenue of $5.86 billion, up 15% year-over-year.

Amid COVID-19 pandemic, the company saw increased customer buying patterns and prescription trends which resulted in a revenue increase of approx. $250 million for the quarter.

The company has adjusted its earnings guidance for the full year 2020.

The graphical representation of the earnings results can be found here.

There was a panic on diabetes meds like insulin, Trulicity etc.. people that take these meds didn’t think there would be a supply or if they lost their job they wouldn’t have coverage. Don’t get all excited, it will tank 2nd quarter! This is what happened to toilet paper with the pandemic! People weren’t going in to get new Rxs, these were refills!

 

[anonymous]

There was a panic on diabetes meds like insulin, Trulicity etc.. people that take these meds didn’t think there would be a supply or if they lost their job they wouldn’t have coverage. Don’t get all excited, it will tank 2nd quarter! This is what happened to toilet paper with the pandemic! People weren’t going in to get new Rxs, these were refills!

Yes, exactly and most switched their RXs to 90-day supplies. Did you see Lantus skyrocketing? There should be no reason for it to do that. Curious about q2, so many things in play right now...

 

[anonymous]

Yes, exactly and most switched their RXs to 90-day supplies. Did you see Lantus skyrocketing? There should be no reason for it to do that. Curious about q2, so many things in play right now...

It is more about suppliers sticking up on inventory in case of a slow down in production.Once everything returns to normal and there’s less fear of a supply shortage then they will let their inventories fall back to the normal range before ordering more. That’s when we will see the dip back in stock price for a quarter or so and then normalize